KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Net Cash Flow: 2014-2024

Historic Net Cash Flow for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to -$495.5 million.

  • BeOne Medicines' Net Cash Flow rose 1857.66% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 444.60%. This contributed to the annual value of -$495.5 million for FY2024, which is 27.23% up from last year.
  • Latest data reveals that BeOne Medicines reported Net Cash Flow of -$495.5 million as of FY2024, which was up 27.23% from -$681.0 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Net Cash Flow registered a high of $3.4 billion during FY2021, and its lowest value of -$681.0 million during FY2023.
  • For the 3-year period, BeOne Medicines' Net Cash Flow averaged around -$538.3 million, with its median value being -$495.5 million (2024).
  • Per our database at Business Quant, BeOne Medicines' Net Cash Flow surged by 780.09% in 2020 and then crashed by 112.96% in 2022.
  • Yearly analysis of 5 years shows BeOne Medicines' Net Cash Flow stood at $751.0 million in 2020, then soared by 350.44% to $3.4 billion in 2021, then crashed by 112.96% to -$438.5 million in 2022, then slumped by 55.31% to -$681.0 million in 2023, then climbed by 27.23% to -$495.5 million in 2024.